These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34080439)

  • 61. Association Between "Unacceptable Condition" Expressed in Palliative Care Consultation Before Left Ventricular Assist Device Implantation and Care Received at the End of Life.
    Nakagawa S; Takayama H; Takeda K; Topkara VK; Yuill L; Zampetti S; McLaughlin K; Yuzefpolskaya M; Colombo PC; Naka Y; Uriel N; Blinderman CD
    J Pain Symptom Manage; 2020 Nov; 60(5):976-983.e1. PubMed ID: 32464259
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Predictors of Placement of Inpatient Palliative Care Consult Orders Among Patients With Breast, Lung, and Colon Cancer in a Safety Net Hospital System.
    Smith LN; Rhodes RL; Xuan L; Halm EA
    Am J Hosp Palliat Care; 2018 Apr; 35(4):586-591. PubMed ID: 29034687
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison of Trends, Mortality, and Readmissions After Insertion of Left Ventricular Assist Devices in Patients <65 Years Vs ≥65 Years.
    Rali AS; Ranka S; Acharya P; Buechler T; Weidling R; Mastoris I; Taduru S; Abicht T; Haglund N; Sauer AJ; Shah Z
    Am J Cardiol; 2020 Aug; 128():16-27. PubMed ID: 32650911
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cost-Effectiveness of Left Ventricular Assist Devices in Ambulatory Patients With Advanced Heart Failure.
    Baras Shreibati J; Goldhaber-Fiebert JD; Banerjee D; Owens DK; Hlatky MA
    JACC Heart Fail; 2017 Feb; 5(2):110-119. PubMed ID: 28017351
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Impact of concomitant cardiac procedures performed during implantation of long-term left ventricular assist devices.
    Morgan JA; Tsiouris A; Nemeh HW; Hodari A; Karam J; Brewer RJ; Paone G
    J Heart Lung Transplant; 2013 Dec; 32(12):1255-61. PubMed ID: 24135274
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of Hospital Ownership on Outcomes After Left Ventricular Assist Device Implantation in the United States.
    Briasoulis A; Inampudi C; Akintoye E; Adegbala O; Bhama J; Alvarez P
    Ann Thorac Surg; 2019 Feb; 107(2):527-532. PubMed ID: 30316859
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Trends and outcomes of device-related 30-day readmissions after left ventricular assist device implantation.
    Briasoulis A; Ueyama H; Kuno T; Asleh R; Alvarez P; Malik AH
    Eur J Intern Med; 2021 Feb; 84():56-62. PubMed ID: 33039191
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Independent risk factors for ICU mortality after left ventricular assist device implantation.
    Piffard M; Nubret-Le Coniat K; Simon O; Leuillet S; Rémy A; Barandon L; Ouattara A
    Artif Organs; 2020 Feb; 44(2):153-161. PubMed ID: 31318978
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Trends and Cost of Heart Transplantation and Left Ventricular Assist Devices: Impact of Proposed Federal Cuts.
    Patel N; Kalra R; Doshi R; Bajaj NS; Arora G; Arora P
    JACC Heart Fail; 2018 May; 6(5):424-432. PubMed ID: 29724365
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Advanced heart failure patients supported with ambulatory inotropic therapy: What defines success of therapy?
    Grubb CS; Truby LK; Topkara VK; Bohnen MS; Yuzefpolskaya M; DeFilippis EM; Kleet A; Nakagawa S; Haythe JH; Axsom K; Colombo P; Takeda K; Uriel N; Sayer G; Garan H; Naka Y; Farr M
    Am Heart J; 2021 Sep; 239():11-18. PubMed ID: 33984317
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Influence of Palliative Care Consultation on Health-Care Resource Utilization During the Last 2 Months of Life: Report From an Integrated Palliative Care Program and Review of the Literature.
    Dunn EJ; Markert R; Hayes K; McCollom J; Bains L; Kahlon D; Kumar G
    Am J Hosp Palliat Care; 2018 Jan; 35(1):117-122. PubMed ID: 28273754
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Impact of cardiac resynchronization therapy on clinical outcomes in patients with continuous-flow left ventricular assist devices.
    Gopinathannair R; Birks EJ; Trivedi JR; McCants KC; Sutton BS; Deam AG; Slaughter MS; Hottigoudar RU
    J Card Fail; 2015 Mar; 21(3):226-32. PubMed ID: 25528199
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Examining the Association between Healthcare Utilization and Clinical Characteristics among Cancer Patients in a Safety Net Health System.
    Knox-Rice T; Xuan L; Wadsworth H; Halm EA; Rhodes RL
    J Palliat Med; 2019 Jan; 22(1):80-83. PubMed ID: 30265596
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Obesity as a Risk Factor for Consideration for Left Ventricular Assist Devices.
    Mohamedali B; Yost G; Bhat G
    J Card Fail; 2015 Oct; 21(10):800-5. PubMed ID: 26093334
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Intraoperative prothrombin complex concentrate administration and outcomes in patients undergoing left ventricular assist device implantation.
    Boswell MR; Stulak JM; Tchantchaleishvili V; Weber MP; Warner MA; Smith BB; Smith MM
    Artif Organs; 2021 Aug; 45(8):E223-E303. PubMed ID: 33469913
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Serotonergic antidepressants and hospitalization for bleeding in patients supported with a continuous flow left ventricular assist device.
    Behrend K; Lillyblad M; Skelton P; Stanberry L; Garberich RF; Eckman PM; Hryniewicz K
    J Heart Lung Transplant; 2021 Dec; 40(12):1599-1604. PubMed ID: 34419371
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Gender Differences Regarding Palliative Care Consultation Among Persons Hospitalized With Heart Failure.
    Blum M; Frydman JL; Zeng L; Hiensch K; Abshire Saylor M; Chai E; Lala A; Goldstein NE; Gelfman LP
    J Pain Symptom Manage; 2024 Nov; 68(5):477-487.e4. PubMed ID: 39127417
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Sex Differences in Left Ventricular Assist Device-related Emergency Department Encounters in the United States.
    Reza N; Edwards JJ; Katcoff H; Mondal A; Griffis H; Rossano JW; Lin KY; Holzhauser HL; Wald JW; Owens AT; Cappola TP; Birati EY; Edelson JB
    J Card Fail; 2022 Sep; 28(9):1445-1455. PubMed ID: 35644307
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Right heart failure and "failure to thrive" after left ventricular assist device: clinical predictors and outcomes.
    Baumwol J; Macdonald PS; Keogh AM; Kotlyar E; Spratt P; Jansz P; Hayward CS
    J Heart Lung Transplant; 2011 Aug; 30(8):888-95. PubMed ID: 21530314
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.